Effect of Dietary Omega-3 Fatty Acids on Tumor-Associated Macrophages and Prostate Cancer Progression

被引:45
|
作者
Liang, Pei [1 ]
Henning, Susanne M. [1 ]
Schokrpur, Shiruyeh [2 ,3 ]
Wu, Lily [2 ,3 ]
Doan, Ngan [4 ]
Said, Jonathan [4 ]
Grogan, Tristan [5 ]
Elashoff, David [5 ]
Cohen, Pinchas [6 ]
Aronson, William J. [1 ,7 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol Pharmacol, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med Pharmacol, Los Angeles, CA 90095 USA
[4] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA
[5] Univ Calif Los Angeles, David Geffen Sch Med, Stat Core, Los Angeles, CA 90095 USA
[6] Univ Southern Calif, Leonard Davis Sch Gerontol, Los Angeles, CA USA
[7] VA Med Ctr Greater Los Angeles Healthcare Syst, Los Angeles, CA USA
来源
PROSTATE | 2016年 / 76卷 / 14期
关键词
fish oil; omega-3 and omega-6 fatty acid; tumor-associated macrophages; allograft prostate tumor; FVB mouse; FATTY-ACIDS; RISK; MEN; CYCLOOXYGENASE-2; EXPRESSION; APOPTOSIS; GPR120; GROWTH; CELLS; N-3;
D O I
10.1002/pros.23218
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUNDPreclinical and clinical studies suggest that a fish oil-based diet may play a role in delaying the progression of prostate cancer through a number of different mechanisms involving inflammatory pathways. Given the importance of tumor-associated macrophages (TAMs) in carcinogenesis, we hypothesized that a fish oil-based diet will inhibit TAM infiltration and delay the growth of prostate cancer. METHODSAndrogen sensitive mouse prostate cancer (MycCaP) allograft tumors were grown in fully immunocompetent FVB mice fed a high- fat fish oil (omega-3) or corn oil (omega-6) diet. Gene expression of markers for immune cell populations, cytokines, chemokines, and signaling pathways were determined by real-time PCR and western blot in tumor tissue. Cell proliferation and apoptosis in vitro were measured by MTS assay and flow cytometry. RESULTSTumor volumes were significantly smaller in mice in -3 versus the -6 group (P=0.048). Gene expression of markers for M1 and M2 macrophages (F4/80, iNOS, ARG1), associated cytokines (IL-6, TNF alpha, IL-10), and the chemokine CCL-2 were also lower in the omega-3 group. Correlative in vitro studies were performed in M1 and M2 polarized macrophages and mirrored the in vivo findings. Dietary fish oil and in vitro omega-3 fatty acid administration reduced protein expression of transcription factors in the nuclear factor kappa B pathway leading to a significant decrease in gene expression of downstream targets (Bcl-2, BCL-XL, XIAP, survivin) in MycCap cells. CONCLUSIONSThese findings underscore the potential of fish oil in modulating the clinical course of human prostate cancer through the immune system. Further preclinical and clinical studies are warranted evaluating fish oil-based therapies for inhibiting the recruitment and function of M1 and M2 tumor infiltrating macrophages. Prostate 76:1293-1302, 2016. (c) 2016 Wiley Periodicals, Inc.
引用
收藏
页码:1293 / 1302
页数:10
相关论文
共 50 条
  • [1] Effect of dietary omega-3 fatty acids on castrate-resistant prostate cancer and tumor-associated macrophages
    Pei Liang
    Susanne M. Henning
    Johnny Guan
    Tristan Grogan
    David Elashoff
    Pinchas Cohen
    William J. Aronson
    [J]. Prostate Cancer and Prostatic Diseases, 2020, 23 : 127 - 135
  • [2] Effect of dietary omega-3 fatty acids on castrate-resistant prostate cancer and tumor-associated macrophages
    Liang, Pei
    Henning, Susanne M.
    Guan, Johnny
    Grogan, Tristan
    Elashoff, David
    Cohen, Pinchas
    Aronson, William J.
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2020, 23 (01) : 127 - 135
  • [3] Effect of omega-3 fatty acid diet on prostate cancer progression and cholesterol efflux in tumor-associated macrophages-dependence on GPR120
    Liang, Pei
    Henning, Susanne M.
    Grogan, Tristan
    Elashoff, David
    Said, Jonathan
    Cohen, Pinchas
    Aronson, William J.
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2023,
  • [4] Omega-3 fatty acids: Implications for the treatment of tumor-associated inflammation
    Jho, D
    Babcock, TA
    Helton, WS
    Espat, NJ
    [J]. AMERICAN SURGEON, 2003, 69 (01) : 32 - 36
  • [5] Prostatic and Dietary Omega-3 Fatty Acids and Prostate Cancer Progression during Active Surveillance
    Moreel, Xavier
    Allaire, Janie
    Leger, Caroline
    Caron, Andre
    Labonte, Marie-Eve
    Lamarche, Benoit
    Julien, Pierre
    Desmeules, Patrice
    Tetu, Bernard
    Fradet, Vincent
    [J]. CANCER PREVENTION RESEARCH, 2014, 7 (07) : 766 - 776
  • [6] Dietary Omega-6 and Omega-3 Fatty Acids and Prostate Cancer - Letter
    Azrad, Maria
    Demark-Wahnefried, Wendy
    [J]. CANCER PREVENTION RESEARCH, 2012, 5 (05) : 798 - 798
  • [7] Dietary Omega-6 and Omega-3 Fatty Acids and Prostate Cancer - Response
    Galet, Colette
    Aronson, William J.
    [J]. CANCER PREVENTION RESEARCH, 2012, 5 (05) : 799 - 799
  • [8] Effects of dietary omega-3 fatty acids on orthotopic prostate cancer progression, tumor associated macrophages, angiogenesis and T-cell activation—dependence on GPR120
    Pei Liang
    Susanne M. Henning
    Tristan Grogan
    David Elashoff
    Huihui Ye
    Pinchas Cohen
    William J. Aronson
    [J]. Prostate Cancer and Prostatic Diseases, 2022, 25 : 539 - 546
  • [9] A Low Dietary Ratio of Omega-6 to Omega-3 Fatty Acids May Delay Progression of Prostate Cancer
    Apte, Shruti A.
    Cavazos, David A.
    Whelan, Kaitlin A.
    deGraffenried, Linda A.
    [J]. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2013, 65 (04): : 556 - 562
  • [10] Effects of dietary omega-3 fatty acids on orthotopic prostate cancer progression, tumor associated macrophages, angiogenesis and T-cell activation-dependence on GPR120
    Liang, Pei
    Henning, Susanne M.
    Grogan, Tristan
    Elashoff, David
    Ye, Huihui
    Cohen, Pinchas
    Aronson, William J.
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2022, 25 (03) : 539 - 546